API SUPPLIERS

API Suppliers

29

US DMFs Filed

19

CEP/COS Certifications

5

JDMFs Filed

0

Other Certificates

3

Other Suppliers

12

API REF. PRICE (USD / KG)

11,098

API Market Place

9

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

Europe

Canada

Australia

South Africa

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

930.00

Annual Reports

0

FDF Market Place

3

EXCIPIENTS

243

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

4

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

3

News

31

REF STANDARD

EDQM

2

USP

2

JP

0

Other Listed Suppliers

4

SERVICES

0

Full Screen View

Reset Filter

Price Info

USP

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Clonidine (200 mg)

PDF Supplier PDF

URL Supplier Web Content

Catalog Number

1140393

CAS Number

4205-90-7

Current Lot

G0G086

Previous Lot

F0C401 (31-MAR-2008)

NDC Code

Unit Price

230

Special Restriction

ASK
US

Upload
your Marketing & Sales content

USP

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

U.S.A

Virtual Booth

Digital Content

Clonidine Hydrochloride (200 mg)

PDF Supplier PDF

URL Supplier Web Content

Catalog Number

1140407

CAS Number

4205-91-8

Current Lot

I0M189

Previous Lot

H1I279 (31-JUL-2014)

NDC Code

Unit Price

230

Special Restriction

ASK
US

Upload
your Marketing & Sales content

List of USP Standards of MolPort-001-684-471 on PharmaCompass.com.

MolPort-001-684-471

MolPort-001-684-471

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

29 API Suppliers

19 USDMF

5 CEP/COS

3 EU WC

17 NDC API

12 Listed Suppliers

DEVELOPMENTS

10 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

DOSSIERs // Finished Dosage Formulations

169 Dossiers

119 FDA Orange Book

13 Europe

11 Canada

8 Australia

4 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

30 Kerry

25 Roquette

21 BASF

13 Seppic

12 Microlex e.U

12 Gangwal Chemicals

12 Sigachi Industries

11 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

9 Gangwal Healthcare

9 Actylis

7 Boai NKY Pharmaceuticals Ltd

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 DFE Pharma

6 Lonza Capsugel

5 SPI Pharma

5 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

4 Prachin Chemical

3 Nanjing Well Pharmaceutical

3 Ulanqab Kema New Material

3 Kima Chemical

2 Jai Radhe Sales

2 Rochem International Inc

2 The Dow Chemical Company

2 DKSH

1 Clariant

1 Pfanstiehl

1 Nanjing Bold Chemical

1 ACG Worldwide

1 Qualicaps

1 Zhejiang Huakang Pharmaceutical

1 Aeon Procare

1 Pharm-RX Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Alcedo Pharmachem

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders

46 Coating Systems & Additives

43 Disintegrants & Superdisintegrants

38 Direct Compression

27 Granulation

TABLET;ORAL - 0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 0.3MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 0.1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 0.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons